Molecular, Cellular and Developmental Biology

��Ҵ�ý�ƽ�� scholars elected members of the National Academy of Sciences

Rachel Sauer — Fri, 01 May 2026 20:47:49 +0000

��Ҵ�ý�ƽ�� scholars elected members of the National Academy of Sciences Rachel Sauer Fri, 05/01/2026 - 14:47

Lee Niswander and Bethany Ehlmann recognized ‘for their distinguished and continuing achievements in original research’

Two University of Colorado Boulder scientists have been elected members of the National Academy of Sciences, joining a cohort of more than 140 scholars around the world who are recognized for their distinguished and continuing achievements in original research.

Lee Niswander, a distinguished professor of molecular, cellular and developmental biology, and Bethany Ehlmann, a professor of geological sciences and director of the Laboratory for Atmospheric and Space Physics.

The National Academy of Sciences is a private, nonprofit institution that was established under a congressional charter signed by President Abraham Lincoln in 1863.

It recognizes achievement in science by election to membership, and—with the National Academy of Engineering and the National Academy of Medicine—provides science, engineering and health policy advice to the federal government and other organizations.

Lee Niswander is a distinguished professor of molecular, cellular and developmental biology.

Pursuing clinical therapies

Niswander is head of the Niswander Lab, where she and her group investigate mouse models of embryonic development to provide insights into fundamental developmental processes, major human birth defects and potential clinical therapies. Her studies have revealed the molecular mechanisms that control formation of the central and peripheral nervous system, as well as lung, limb and neuromuscular development.

Niswander’s current focus is on early brain formation and birth defects that arise when normal brain formation goes awry, like failure of neural tube closure or maintenance of neural progenitor cells, resulting in spina bifida or microcephaly.

The Niswander Lab uses the mouse embryo and human-induced pluripotent stem cells as models of human development. The lab’s studies encompass genetics, epigenetics, environmental factors and live imaging to couple molecular insights to cell behaviors. Through collaborative efforts, Niswander Lab researchers are also exploring the genetic causes of neural tube defects in humans.

Niswander recently received the Hazel Barnes Prize, which celebrates the enriching interrelationship between teaching and research. It is the largest and most prestigious award funded by the university. This summer she will be honored with an Edwin G. Conklin Medal, which is awarded annually by the Society for Developmental Biology (SDB) to recognize a developmental biologist who has made and is continuing to make extraordinary research contributions to the field and is an excellent mentor, helping train the next generation of outstanding scientists.

Niswander received her bachelor’s degree in chemistry from ��Ҵ�ý�ƽ��, her master’s degree in biochemistry and genetics from University of Colorado Health Sciences Center (now CU Anschutz) and her doctorate in genetics from Case Western University. She performed her postdoctoral training in developmental biology at the University of California San Francisco.

“I am deeply honored to become a member of the National Academy of Sciences,” Niswander says. “I am grateful to the numerous trainees and their research discoveries that provided the foundation of this honor. I am excited to join the Academy in their mission to advise on scientific matters important for human health.”

Bethany Ehlmann is a professor of geological sciences and director of the Laboratory for Atmospheric and Space Physics.

Studying space

Ehlmann is a planetary scientist who holds the faculty roles of Provost’s Chair in the Research and Innovation Office and affiliate professor in the Department of Astrophysical and Planetary Sciences. Her research focuses on water in the solar system, the evolution of habitable worlds and remote sensing techniques and instruments for planetary missions.

Ehlmann is a science team member of multiple missions, including the Jupiter-bound Europa Clipper; the Earth-orbiting EMIT imaging spectrometer; the Mars Science Laboratory Curiosity rover; the Mars2020 Perseverance rover; the ExoMars rover; and orbiting and landed spectrometers for the Artemis lunar program. Previously, she was a science team member for the Mars Reconnaissance Orbiter CRISM instrument, the Dawn mission during its exploration of the asteroid Ceres, the Mars Exploration Rovers Spirit and Opportunity and principal investigator of Lunar Trailblazer.

Active in science policy and outreach, Ehlmann is president of the board of directors of The Planetary Society. She served as a member of the National Academies Planetary Science and Astrobiology Decadal Survey and the National Academies Committee on Astrobiology and Planetary Science. She is a fellow of both the American Geophysical Union and the Mineralogical Society of America, and has authored a children's book, “Dr. E's Super Stellar Solar System,” with National Geographic.

Ehlmann earned a bachelor’s degree from Washington University, where she double majored in earth and planetary sciences and environmental studies with a minor in math; two master’s degrees from the University of Oxford, in environmental change and management and geography; and master’s and doctoral degrees in geological sciences from Brown University.

Did you enjoy this article? Subscribe to our newsletter. Passionate about arts and sciences? Show your support.

Lee Niswander and Bethany Ehlmann recognized ‘for their distinguished and continuing achievements in original research.’

Traditional

White

Sometimes you just feel like a mango

Rachel Sauer — Wed, 15 Apr 2026 14:48:12 +0000

Sometimes you just feel like a mango Rachel Sauer Wed, 04/15/2026 - 08:48

Rachel Sauer

In new mid-grade novel Confessions of a Mango, writing team Katheryn Lumsden and Nathan Pieplow explore the challenges of navigating middle school with a dyslexia diagnosis

Have you ever felt like the mango in a line of lovebirds? Sure, you look like you fit in—same general shape, same red, yellow and green coloring—but, well, you’re a mango and everyone else is a bird.

That’s how Ruby Emmerson feels at Benton Academy, where she’s starting sixth grade with her twin brother, Bryce. But while Bryce is an academic high achiever who likely will excel at the competitive charter school, Ruby’s diagnoses of dyslexia, dysgraphia and dyscalculia mean that reading, writing and math are tough for her.

And when she fails her first test at Benton, wow, does she feel like a mango. She even writes a brief blog post about it: “I dont belong at Benton Acadamy. I’m an imposter. I walk beside you in the halls every day. But I’m not smart enuff to stay much longer. Theres so much work. Im failing.”

Nathan Pieplow (left) and Katheryn Lumsden (right) are the authors of Confessions of a Mango, a new mid-grade novel that explores questions of belonging.

Except . . . so many of her classmates relate. Just as readers likely will.

Ruby’s are the confessions in Confessions of a Mango, a mid-grade novel published this week and written by Katheryn Lumsden, a University of Colorado Boulder molecular, cellular and developmental biology alumna, and Nathan Pieplow, an associate teaching professor in the Program for Writing and Rhetoric.

But for the purposes of this book, they are Kate and Nate, a writing team with way too many ideas and way too little time, and a shared passion for telling honest stories with humor and empathy.

“This is the first creative partnership I’ve been in that works,” Pipelow says. “We bicker like siblings, but the beautiful thing about writing with Katheryn is she’s an idea factory. She can write 2,000 words in an afternoon, then she sends them to me, and I don’t have to start with a blank page.”

“I’m the sloppy copy,” she says.

“I contribute ideas,” he says.

“He’s the atmosphere and the voice. Ironically, Mango didn’t have my voice until he added it.”

It just works, they conclude.

A writing partnership is born

Pieplow and Lumsden met, unsurprisingly, in a Boulder writing group six years ago. Lumsden, a pharmacist by profession, was a longtime group member who wanted a community of support to help her wrangle her boundless ideas. Pieplow, who had authored two field guides to bird sounds, wanted to delve into fiction writing.

“Everyone was like, ‘Why is he here? He doesn’t have plots,’” Lumsden recalls. “But I didn’t have pretty writing and he does, so I decided, ‘I’m gonna ask Nathan if he wants to meet'—for me it was so that he could teach me how to write better, and for him it was so I could teach him how to plot.”

Author event

Katheryn Lumsden and Nathan Pieplow will talk about Confessions of a Mango Thursday evening at Boulder Bookstore.

What: Book discussion of Confessions of a Mango

Who: Authors Katheryn Lumsden and Nathan Pieplow

Where: Boulder Bookstore, 1107 Pearl St.

When: 6:30 p.m. Thursday, April 16

Reserve a spot

And so, a writing partnership was born. Their first book was a young adult historical fantasy that was good enough to get them their agent, Sarah Fisk, but it wasn’t bought by a publisher. The next novel wasn’t, either.

“If you want to be a fiction writer, you write several (books) and if one doesn’t get published, you move on to the next,” Lumsden says.

“(Confessions of a Mango) is definitely our debut,” Pieplow adds. “The first two were not quite at this level; with our first ones we were playing with form and voice.”

In fact, Fisk told them that the most important thing to get right when writing mid-grade or young adult fiction is the voice, Lumsden says, “and fortunately, voice has always been one of the things I do well.”

The idea for Confessions of a Mango germinated from many seeds. Lumsden grew up in Boulder with a twin brother who, like Bryce, was considered the “smart” one. Lumsden struggled with reading, and their mom, not wanting to make Lumsden feel bad, took both of them for dyslexia testing, explaining it away with “people are interested in twins.”

She did learn to navigate dyslexia, however, so when she was 12, her mom brought home a cake as a sort of “Congratulations for outgrowing dyslexia!” celebration. “Except it wasn’t until much later that I found out you don’t actually outgrow dyslexia,” Lumsden says.

She also read Overcoming Dyslexia by Sally Shaywitz and ideas began percolating. So, when Pieplow went on a birding trip for a month, Lumsden grew impatient waiting for his return and started writing a book.

Making it realistic and relatable

“Part of it was that I was so angry,” she explains. “So often, these kids (diagnosed with dyslexia) don’t know how smart they truly are, and that’s so unfair. Plus, they never see themselves in books because dyslexia just isn’t something that gets written about in mid-grade fiction.

Confessions of a Mango tells the story of Ruby Emmerson, a sixth grader at Benton Academy whose diagnoses of dyslexia, dysgraphia and dyscalculia make her feel like she doesn't fit in at the competitive charter school.

“So, when Nathan got back, I sent him what I’d started and he was like, ‘This is actually very good.’”

Lumsden had an advantage because when the two began writing Confessions of a Mango three years ago, her son was 10 and her daughter was 12—she had a front-row seat to the joys and concerns of children entering and navigating middle school.

Pieplow says it was important to them to write a book that was realistic and relatable: The parents may be occasionally clueless, but they want what’s best for their kids. The teachers and administrators at the school are supportive, and the other kids may be squirrelly sometimes, but they’re otherwise normal, decent kids.

“I grew up in Boulder and my husband and I are raising our kids in Boulder, and the parents here are fantastic, but sometimes there can be this feeling of life or death if you don’t do well (in school),” Lumsden says. “There isn’t a lot of room to fail, and people sometimes won’t even say the word ‘fail’ to kids. But it’s important that kids know sometimes they’ll fail and it’s not the end of the world.”

When Fisk began pitching their draft to publishers—after suggesting they excise this chapter and add that chapter, and put in more about Ruby’s quirky best friend, Thea—Little, Brown was the first to make an offer and was the publisher they ultimately chose.

Part of that decision, they say, was the kindness that Little, Brown staff showed them throughout the publishing process—how included they felt in every step and how Little, Brown representatives embraced the dyslexia angle of their story. In fact, Confessions of a Mango is printed in the Lexend font, which improves reading performance and reduces visual stress for people with dyslexia.

They even had a significant say in the vibrant book cover, which shows a girl seated in the shadow of a huge mango with a lovebird perched on its leaf. When they and artist Andy Smith settled on two cover finalists, they asked Lumsden’s son and his friends to vote for their favorite one.

Now, in publication week, a three-year process is finally tangible with the book in readers’ hands. It’s a book close to their hearts, Lumsden says, and they’re proud of the story it tells and the children to whom it gives a literary voice.

But, well, on to the next. They already have several books in progress, and “one of the things I love about working with Katheryn is that eventually we’re going to write something in every genre, because of the exploration of (writing) and how it’s like travel,” Pieplow says. “I love seeing new places, and that’s what I’m doing through the books we’re writing.”

Did you enjoy this article? Subscribe to our newsletter. Passionate about writing and rhetoric? Show your support.

In new mid-grade novel Confessions of a Mango, writing team Katheryn Lumsden and Nathan Pieplow explore the challenges of navigating middle school with a dyslexia diagnosis.

Traditional

White

��Ҵ�ý�ƽ�� scientists honored as AAAS fellows

Rachel Sauer — Thu, 26 Mar 2026 14:20:24 +0000

��Ҵ�ý�ƽ�� scientists honored as AAAS fellows Rachel Sauer Thu, 03/26/2026 - 08:20

Scholars Rebecca Safran and Tin Tin Su recognized by the American Association for the Advancement of Science for excellence in research, teaching and interpreting science to the public

Rebecca Safran, a professor of ecology and evolutionary biology who has led groundbreaking research on the evolution of new species, and Tin Tin Su, professor and chair of molecular, cellular and developmental biology whose research is leading to novel cancer therapies, have been named fellows of the American Association for the Advancement of Science (AAAS).

The AAAS fellowship is among the highest honors in the scientific community, recognizing a distinguished cohort of scientists, engineers and innovators who “have been recognized for their achievements across disciplines, from research, teaching and technology to administration in academia, industry and government, to excellence in communicating and interpreting science to the public,” AAAS officials note.

“This year’s AAAS Fellows have demonstrated research excellence, made notable contributions to advance science and delivered important services to their communities,” says Sudip S. Parikh, AAAS chief executive officer and executive publisher of the Science family of journals. “These Fellows and their accomplishments validate the importance of investing in science and technology for the benefit of all.”

Rebecca Safran is a professor of ecology and evolutionary biology who has led groundbreaking research on the evolution of new species.

A study of swallows

Safran, whose passion for biology took root in a plant taxonomy class during her undergraduate studies at the University of Michigan, and her research team, study the evolution of new species, focusing on the causes and consequences of individual variation across different scales of time and space.

Because studying the formation of new species can be difficult—given that most species are millions of years old and what caused them to diverge from their ancestors often can’t be determined—Safran and her team study barn swallows, a very closely related group of populations of migratory birds that are currently diverging. This allows Safran and her team to study the process of speciation in real time.

Safran won a National Science Foundation Early Career Development award to study speciation in barn swallows across their entire, expansive breeding range throughout the Northern Hemisphere and Middle East. During the COVID-19 pandemic, when it wasn’t possible to conduct research in other countries, Safran and her research team began focusing on the rapid decline in the population of barn swallows and its implications. For their work, Safran and team study the birds using a highly integrative approach including behavioral, physiological and genetic perspectives.

Among other discoveries, Safran and her team found that sexual selection, or the process by which organisms choose mates based on traits they find attractive, drives the emergence of new species. Her team’s research has been published in more than 120 peer-reviewed journals, including Science, Nature and Current Biology. She also co-edited a recent book on speciation (2024, Cold Spring Harbor Press).

“None of this work is possible without the incredible collaboration with students, colleagues at CU and around the world, private landowers who allow us to study populations of barn swallows on their properties and continuous funding support by the National Science Foundation and other agencies,” Safran says. “I am especially honored to have worked with so many talented undergraduate, graduate and postdoctoral students."

Studying fruit flies to treat cancer

Su, who attended Woodstock School in Mussoorie, Uttarakhand, India, credits her experiences there, in part, with helping her understand that her ideal environment is one in which “you do respect the elders or people who have had more experience or authority. But at the same time, if it doesn't seem right, you question it.”

Tin Tin Su is a professor and chair of molecular, cellular and developmental biology whose research is leading to novel cancer therapies.

Throughout her career, Su and her research colleagues have sought to develop new ways of attacking cancer. Through research on how tissues and organs in fruit flies regenerate after being damaged by X-rays, they synthesized the chemical SVC112, which helps prevent cancer cells from regrowing following radiation exposure. Su and her colleagues focused on the fruit fly because this insect shares more than 70% of disease-relevant genes with humans.

SVC112 is based on the chemical bouvardin found in the firecracker bush (Bouvardia ternifolia) that grows in the Southwest United States and Mexico. Su and her colleagues discovered that bouvardin can prevent regeneration of tissues in fruit flies.

More recently, Su, who also is a member of the CU Cancer Center, and her colleague Antonio Jimeno, co-leader of the CU Cancer Center’s Developmental Therapeutics Program, used SVC112 to target cancer stem cells in head and neck cancers. They are in the process of applying to the FDA to test SVC112 in human trials.

Su also has participated in the ��Ҵ�ý�ƽ�� Community Perspectives Program, conducting outreach in several rural Colorado communities that led to a research collaboration with Colorado State University Pueblo to assess the effect of heavy metals on the genome in fruit fly and human cells.

“I do what I do because I love science,” Su says. “The potential to help cancer patients in Colorado and beyond makes it even better. So, to be named a AAAS Fellow is really the cherry on top!”

��Ҵ�ý�ƽ�� the AAAS Fellowship

The AAAS began naming fellows annually in 1874, people nominated by the AAAS Council to recognize those whose “efforts on behalf of the advancement of science or its applications are scientifically or socially distinguished.”

Safran and Su join a cohort of more than 80 ��Ҵ�ý�ƽ�� faculty members who previously received the honor, as well as a broader cadre that includes Thomas Edison, W.E.B DuBois, Maria Mitchell, Steven Chu, Ellen Ochoa and Irwin M. Jacobs.

Did you enjoy this article? Subscribe to our newsletter. Passionate about natural sciences? Show your support.

Scholars Rebecca Safran and Tin Tin Su recognized by the American Association for the Advancement of Science for excellence in research, teaching and interpreting science to the public.

Traditional

White

Scientist lives by the Serengeti Rules

Rachel Sauer — Tue, 17 Mar 2026 02:17:06 +0000

Scientist lives by the Serengeti Rules Rachel Sauer Mon, 03/16/2026 - 20:17

Rachel Sauer

Author, filmmaker and scholar Sean B. Carroll, formerly a ��Ҵ�ý�ƽ�� postdoctoral researcher, will deliver the Rose M. Litman Memorial Lecture in Science April 7

When Sean B. Carroll came to the University of Colorado Boulder in 1983, right out of graduate school and newly hired as a postdoctoral researcher in the lab of molecular, cellular and developmental biologist Matt Scott, he was somewhat indifferent to Drosophila melanogaster, better known as the fruit fly and Scott’s research focus.

“I was coming from an immunology background, working with furry animals, and my attitude was that studying fruit flies wouldn’t teach us anything general,” Carroll recalls. “It wouldn’t have anything to do with humans or important things, or so I thought. But that was a really narrow view, because it turns out that all these genes that build fruit fly parts are in us—they build parts in us—so fruit flies became a passport to the whole animal kingdom.”

Scientist, author and filmmaker Sean B. Carroll, a former ��Ҵ�ý�ƽ�� postdoctoral researcher, will deliver the Rose M. Litman Memorial Lecture in Science April 7.

And with that passport, Carroll has roamed the planet as an evolutionary developmental biologist and award-winning author and filmmaker, observing life from individual cells to continent-spanning populations. Through his observations and experiences emerged what he came to call “The Serengeti Rules,” based on the idea that everything in the living world is regulated.

He will discuss the discovery of The Serengeti Rules, on which he elaborates in his book of the same name, during the Rose M. Litman Memorial Lecture from 4-5 p.m. April 7 in the CASE Chancellor’s Hall Auditorium.

The Serengeti Rules, as he describes them, are ecological rules that regulate the numbers and kinds of animals and plants in any given place, and how they are being applied to restore some of the greatest wildernesses on the planet.

“Every cell contains a society of molecules, every organ a society of cells, every body a society of organs, every habitat a society of organisms,” he writes in The Serengeti Rules. “Understanding the interactions within each of those societies are the primary aims of molecular biology, physiology and ecology.”

Diversity in the animal kingdom

Before he had roamed the globe as a scientist and filmmaker, however, Carroll was the kid growing up in Toledo, Ohio, flipping over rocks to see what was under them. “I have a love for the entire animal kingdom,” he explains, which guided him to a bachelor’s degree in biology from Washington University and a PhD in immunology from Tufts University.

During his graduate studies, he became very interested in the question of how animal bodies evolve—in understanding how all the diversity in the animal kingdom came about. So, he hatched a plan to solve the mysteries of development.

“Changes in development are what lead to changes in form,” Carroll says. “The whole diversity of the animal kingdom is rooted in development, so we had to crack the black-box mystery of development to get any traction in understanding how the physical diversity of the animal kingdom evolved.”

Thus, the fruit flies. He wagered that studying them could be a key to unlocking the diversity of the animal kingdom—and the genes that govern development—and came to ��Ҵ�ý�ƽ�� determined to pick the lock on that black box.

If you go

What: 2026 Rose M. Litman Memorial Lecture in Science—The Serengeti Rules: The Regulation and Restoration of Biodiversity

Who: Sean B. Carroll

When: 4–5 p.m. Tuesday, April 7, with reception to follow

Where: Chancellor’s Hall Auditorium, Center for Academic Success & Engagement (CASE)

Learn more

“During this time, 1983, oh my god—how an egg turns into a complex creature was a mystery,” he says. “It was a spectacular pageant we could watch from the outside, but we didn’t know what was going on inside. We needed to identify the genes that are necessary for that process, figure out what the genes did.

“It’s hard to overstate both how deep the mystery was but how thrilling these clues were as they started to unfold. Those days were incredibly exhilarating and intense, the lab was a beehive, people worked all days and nights and weekends because, first of all, we were fascinated. Also, we felt we had a shot at some really fundamental discoveries. Looking back, these times don’t happen very often in science where you really have a black-box mystery, and it breaks open—and it broke open partly because of what we did in Matt’s lab and partly because of what our peers around the world did.”

One eureka moment from Carroll’s time in Boulder came about 18 months into his research. He had taken on the task of seeing genes in action inside developing fruit fly embryos, working every day in the lab, trying this technique and that technique until his bag of tricks was almost empty; he was no closer to understanding which genes caused wings to grow, for example, or determined their shape.

He remembers a particular time when he took his samples down to a borrowed microscope, flipping on an ultraviolet light because he was looking at fluorescence, “and the best thing I can say is that it was a ‘holy sh^t!’ moment. I remember looking down, and I saw these embryos that had these beautiful green rings circling them, which is the mark of a gene that turns on every other segment.

“That’s the day when the dam broke, the door blew open, the clouds parted. It’s almost overwhelming because now so many things are possible. I went from having nothing to show anybody to essentially having the tools that would allow me to really untangle this puzzle.”

During his April 7 lecture, Sean B. Carroll will discuss the Serengeti Rules, the ecological rules that regulate the numbers and kinds of animals and plants in any given place, and how they are being applied to restore some of the greatest wildernesses on the planet.

A discovery of wings

After completing his ��Ҵ�ý�ƽ�� postdoc, Carroll joined the faculty at the University of Wisconsin Madison, where he continued studying the genes that control animal body patterns and play major roles in the evolution of animal diversity. There he “saw something in the microscope that nobody had ever seen before,” he remembers.

He and the other researchers in his lab isolated the handful of genes that are activated in caterpillars to become butterfly wings. This discovery, published in the journal Science, garnered a feature in The New York Times, an interview on PBS News Hour and an invitation to the White House Correspondents’ Association dinner.

From there, Carroll built a career that marries both research and discovery with science communication—as an investigator and vice president for science education at the Howard Hughes Medical Institute (HHMI) and head of the HHMI Tangled Bank Studios, where he executive produced or was executive in charge of more than 30 documentary films, including the Oscar-nominated and Peabody-winning All That Breathes. He has won three Emmys and been nominated for an additional five.

During that time, “I decided, ‘I’m telling the same story again and again, so I probably should write this down,’” he says. “So, I wrote a book, then I wrote another book.” He has written six books, including Remarkable Creatures: Epic Adventures in the Search for the Origins of Species, which was a finalist for the 2009 National Book Award for nonfiction, and The Serengeti Rules: The Quest to Discover How Life Works and Why It Matters, which will be the foundation for his ��Ҵ�ý�ƽ�� lecture.

Carroll, who is a distinguished university professor and the Andrew and Mary Balo and Nicholas and Susan Simon Chair of Biology at the University of Maryland, credits the depth and success of his career in large part to the collaborations of which he’s been a part. “I like to think my toolkit has grown over the years, but it doesn’t happen all at once and it doesn’t happen alone. I didn’t write a full-length book until I was 45 and truly an expert in my field.

“I think people might look at my portfolio and say the science portfolio is pretty good, the external indicators are good; the writing career, there’s been a fair amount of output; the film career has been good. But in no way could I have done it alone. Science is a hugely collaborative thing; filmmaking’s even more collaborative. An individual like me gets a lot of credit for a body of work owned by an enormous community.”

Through it all—from his extensive travels through the Serengeti to the red carpet at the Academy Awards to the quiet moments in the lab—the joy of discovery and mystery-solving has never ebbed, he says. “I love science because I love nature and I love trying to figure out how nature works. I love the privilege and thrill of peeking into that box and going, ‘Oh, my gosh, that’s how it is.’”

��Ҵ�ý�ƽ�� the Rose M. Litman Memorial Lecture in Science

The Litman Lecture celebrates the legacy of an exceptional scientist and educator with a lifelong passion for research and a firm commitment to keeping rigorous inquiry at the heart of university life.

Did you enjoy this article? Subscribe to our newsletter. Passionate about molecular, cellular and developmental biology? Show your support.

Author, filmmaker and scholar Sean B. Carroll, formerly a ��Ҵ�ý�ƽ�� postdoctoral researcher, will deliver the Rose M. Litman Memorial Lecture in Science April 7.

Traditional

White

Three ��Ҵ�ý�ƽ�� faculty named 2026 Sloan Research Fellows

Rachel Sauer — Tue, 17 Feb 2026 16:05:06 +0000

Three ��Ҵ�ý�ƽ�� faculty named 2026 Sloan Research Fellows Rachel Sauer Tue, 02/17/2026 - 09:05

Fellowships provide $75,000 in funding for early-career researchers in fields including chemistry, physics, neuroscience and mathematics

Three University of Colorado Boulder faculty members have been selected to receive prestigious Sloan Research Fellowships in 2026. Winners receive a two-year, $75,000 fellowship that can be used flexibly to advance their research.

The three College of Arts and Sciences faculty members are:

Erica Nelson, assistant professor in the Department of Astrophysical and Planetary Sciences, for physics.
Andres Montoya-Castillo, assistant professor in the Department of Chemistry, for chemistry.
Kelsie Eichel, assistant professor in the Department of Molecular, Cellular and Developmental Biology, for neuroscience.

“The Sloan Research Fellows are among the most promising early-career researchers in the U.S. and Canada, already driving meaningful progress in their respective disciplines,” said Stacie Bloom, president and CEO of the Alfred P. Sloan Foundation, in announcing the winners Tuesday. “We look forward to seeing how these exceptional scholars continue to unlock new scientific advancements, redefine their fields and foster the wellbeing and knowledge of all.”

��Ҵ�ý�ƽ�� researchers (left to right) Erica Nelson, Andres Montoya-Castillo and Kelsie Eichel have been named 2026 Sloan Research Fellows.

For 2026, the Alfred P. Sloan Foundation named 126 early-career researchers—including Nelson, Montoya-Castillo and Eichel—as Sloan Research Fellowship award winners. Fellows from this year’s cohort were drawn from 44 institutions across the United States and Canada.

Since the first Sloan Research Fellowships were awarded in 1955, 60 faculty from ��Ҵ�ý�ƽ�� have received one, including this year’s winners, according to the Alfred P. Sloan Foundation.

“I’m delighted and honored to receive the support of the Sloan Foundation,” Montoya-Castillo said. “I’m especially grateful to my group, mentors and senior colleagues, both at CU and beyond, who have been immensely supportive and kind.”

“It’s a big honor to be recognized by the Sloan Foundation,” Eichel agreed, adding that she is appreciative of the funding for her research. “My lab studies a fundamental question in cellular neuroscience—how neurons build and maintain their polarized architecture. This polarized architecture enables the nervous system to communicate, adapt and ultimately generate behavior. By uncovering the core principles that govern neuronal function, our work will lay the groundwork for developing new strategies to restore neuronal function in neurological diseases.”

Nelson said she is thrilled to be named a Sloan Research Fellow and added that the fellowship funding will be a valuable asset to her research.

“We’ve discovered mysterious red objects in the early universe with the James Webb Space Telescope that challenge what we thought we knew about the first galaxies and black holes. This fellowship provides crucial support to determine what these objects really are: Are they massive galaxies or a never-before-seen phase in the formation of supermassive black holes? Whatever the answer, it will fundamentally reshape our understanding of cosmic dawn in our universe,” she said.

Sloan Research Fellowships are considered one of the most prestigious awards available to young researchers—in part because so many past fellows have gone on to become distinguished figures in science. To date, 59 fellows have won a Nobel Prize, 72 fellows have received the National Medal of Science, 17 have won the Fields Medal in mathematics and 25 have received the John Bates Clark Medal in economics.

Open to scholars in seven fields—chemistry, computer science, Earth systems, economics, mathematics, neurosciences and physics—more than 1,000 researchers are nominated by their fellow scientists each year, according to the Alfred P. Sloan Foundation. The organization said winners are selected by independent panels of senior scholars based upon their research accomplishments, creativity and potential to become leaders in their fields.

Did you enjoy this article? Subscribe to our newsletter. Passionate about arts and sciences? Show your support

Fellowships provide $75,000 in funding for early-career researchers in fields including chemistry, physics, neuroscience and mathematics.

Traditional

White

Grad’s work fuses the arts and sciences

Rachel Sauer — Fri, 12 Dec 2025 20:14:26 +0000

Grad’s work fuses the arts and sciences Rachel Sauer Fri, 12/12/2025 - 13:14

Bradley Worrell

Olivia Neilly, who is earning a double major in English and molecular, cellular and developmental biology with a perfect 4.0 GPA, is named the college’s outstanding graduate for fall 2025

When Olivia Neilly stepped onto the University of Colorado Boulder campus four years ago, she thought she had her future mapped out.

“I really wanted to go to medical school,” she recalls. “I thought I’d keep my head in the books for four years and then move on.”

However, in pursuit of courses that would prepare her for the medical field, Neilly joined Professor Zoe Donaldson’s neuroscience lab in the Department of Molecular, Cellular and Developmental Biology (MCDB)—and that one experience changed everything for her.

Olivia Neilly is the Fall 2025 College of Arts and Sciences outstanding graduate. (Photo: Julie Chiron)

“I discovered that research is not just about data—it’s about asking questions, embracing creativity and finding joy in discovery,” Neilly says. “It literally changed the trajectory of what I want to do with my life, and now I can’t imagine wanting to do anything else.”

Donaldson and Jenny Knight, professor of molecular, cellular and developmental biology, became important mentors for Neilly, whom she credits with fostering creativity and curiosity in the lab. Additionally, PhD graduate Mostafa El-Kalliny helped shape her thinking about research as well as issues outside of science.

“From day one in the lab I worked with Mostafa, who shaped how to think about science—and other subjects,” she says. “Our conversations weren’t just about experiments—they were about philosophy, literature and life.”

Embracing neuroscience with a passion

For her honor’s thesis, Neilly wrote a 71-page research paper investigating how a small part of the brain called the nucleus accumbens helps animals form close social bonds, research that has potential implications for humans. Her paper specifically explored the neuroscience of social bonding on prairie voles, a small species of furry rodents.

“We study prairie voles because they form lifelong pair bonds, like humans,” Neilly explains. “My project focused on nucleus accumbens, a brain region tied to reward. I used chemogenetics (a technique that makes use of engineered proteins) to turn off specific interneurons during bond formation. When those cells were silenced, voles couldn’t form pair bonds. This suggests one cell type can influence complex social behavior, which has implications for psychiatric disorders.”

Neilly began her lab work with the voles before the start of her sophomore year and spent two summers working full time in the lab. This past summer, she completed the experiment underlying her thesis and spent the school year analyzing the data and writing. While the work was very time consuming, Neilly adds, “It never felt like a burden—I loved the process.”

In addition to that work, Neilly authored a manuscript for the scientific journal Nature Communications as well as a second manuscript currently being considered for publication.

Earning high praise from faculty

Neilly was nominated for the outstanding graduate award by Christy Fillman, chair of the MCDB Honors Committee, and Donaldson, who praised her undergraduate student for her curiosity, intellect and strong work ethic.

“I would often find Olivia in the lab at all hours, eager to contribute and learn new skills. By this time last year, she was already operating at the level of a graduate student despite being only a junior. She accomplished this while also maintaining a 4.0 GPA in two majors and maintaining her involvement in other activities, including the American Lung Cancer Society Screening Initiative,” Donaldson wrote in her letter recommending Neilly for the outstanding graduate honor. Donaldson added, “She is the most impressive undergraduate I have had the chance to mentor or interact with across institutions I have worked at.”

Neilly says receiving the outstanding graduate award is both exciting and humbling.

“My mentor (El-Kalliny) hinted that I might get nominated, but honestly, I was so focused on graduating and finishing classes that I didn’t think much about it. When I got the email and Donaldson announced the award in our lab group chat, I was really touched,” Neilly says. “I’m emotional by nature, so it meant a lot that people I respect recognized my efforts. I usually just put my head down and work, not for recognition, so this felt validating. I was proud—and excited to tell my mom first.”

Olivia Neilly (second from left), Fall 2025 College of Arts and Sciences outstanding graduate, chats with, left to right, Daryl Maeda, interim dean of the College of Arts and Sciences; Irene Blair, dean of natural sciences; and Jennifer Fitzgerald, interim associate dean for student success. (Photo: Julie Chiron)

Balancing science and the arts

Neilly’s academic path has proven to be as unique as her research. Initially focused on MCDB, she opted to add an English degree to feed her artistic side.

“At first, I thought there was no overlap,” she recalls. “I started with MCDB for medical school or research but then added English because I missed my artistic side. Over time, I realized they overlap in surprising ways. In science, clear communication is essential—especially now, in a media environment riddled with so much misinformation."

As a creative writer and fan of modern fiction, Neilly applauds how people are pushing the boundaries of language in the same way that scientists are pushing the boundaries of scientific knowledge—celebrating the unbounded exploration of both art and science.

“Writing skills from English help me convey research effectively. Creativity is key in both fields. The best scientists are often the most creative.”

Life beyond the lab

Despite her demanding academic schedule, Neilly says she made time for extracurricular activities. She wrote articles for the online magazine Her Campus, attended film festivals and organized a lung cancer awareness event at Boulder’s historic Chautauqua Park.

She says she feels fortunate to have partaken in many cultural events offered by ��Ҵ�ý�ƽ�� and by the local community, and she encourages her fellow students to do the same, adding, “Connecting with your community matters as much as academics.”

As for any advice for incoming CU students, Neilly says, “Wherever you are, you can make the most of it if you put in the time and energy. Be willing to try new things and embrace discomfort—it’s how you grow.”

Right where she was supposed to be

Neilly says she’s grateful for her time at ��Ҵ�ý�ƽ�� and is now looking forward to what comes next as she prepares to embark on a scientific career. After graduating later this month, Neilly will join Stanford University as a research technician in Boris Heifets’ lab, where scientists study how psychoactive compounds can help treat severe psychiatric disorders.

“I’m passionate about improving mental health and social functioning, so this feels like the right next step before starting grad school,” she says.

Perhaps ironically in retrospect, Neilly says she wasn’t initially committed to attending ��Ҵ�ý�ƽ��. She earned good grades in high school and had a number of options when it came time to select a university.

“I have a long family history with CU; my mom, sister and grandfather all have ties here. At first, I thought I wanted to break the pattern, but my mom reminded me that education is what you make of it,” says Neilly, who spent much of her childhood in Aurora. “CU ended up being the best decision. I found incredible mentors and research opportunities I wouldn’t have had elsewhere.

“I don’t regret a thing. I’ve used CU to the absolute ends of what it could offer.”

Did you enjoy this article? Subscribe to our newsletter. Passionate about arts and sciences? Show your support.

Olivia Neilly, who is earning a double major in English and molecular, cellular and developmental biology with a perfect 4.0 GPA, is named the college’s outstanding graduate for fall 2025.

Traditional

White

Top photo: Olivia Neilly (second from left), Fall 2025 outstanding graduate, with, left to right, Daryl Maeda, interim dean of the college; Irene Blair, dean of natural sciences; and Jennifer Fitzgerald, interim associate dean for student success

Research on python hearts has possible implications for human medicine

Rachel Sauer — Wed, 22 Oct 2025 20:30:32 +0000

Research on python hearts has possible implications for human medicine Rachel Sauer Wed, 10/22/2025 - 14:30

Blake Puscher

��Ҵ�ý�ƽ�� scientists discover the growth of new tissue in Burmese python hearts, which may be transferrable to mammals

Heart disease is the top cause of death in the United States, resulting in one in three deaths in 2023. In addition to being such a vital organ, the adult heart, unlike other parts of the body, cannot heal itself, only adapt to the damage caused by cardiac events like heart attacks.

In cases of minor injuries like skin wounds, damaged tissue grows back as the surrounding cells begin to replicate themselves and ultimately replace what was lost or damaged. Because cells in developed hearts cannot replicate, they must instead change in size and organization to adapt, but this process is itself pathological and will eventually lead to heart failure if the underlying issue is left untreated.

All of this is true in humans, but there are some examples of animals that can grow new heart cells even after the early stages of their development. Newts, zebrafish and spiny mice can all restart the mitotic reproduction of heart cells as adults in response to cardiac injury. In a previous study of hypertrophy—the process adult human hearts use to adapt to damage—in Burmese pythons, University of Colorado Boulder researchers discovered that the snakes’ heart cells can replicate themselves, too, under certain conditions.

��Ҵ�ý�ƽ�� postdoctoral researcher Yuxiao Tan and his research colleagues are studying the mechanism by which pythons' heart cells are enabled to replicate and how it could be transferred to mammals.

Yuxiao Tan, Thomas Martin, Angela Peter, Christopher Ozeroff, Christopher Ebmeier, Ryan Doptis, Brooke Harrison and Leslie Leinwand conducted a recently published follow-up study based on this information, not only discovering a fuller, dynamic model of how pythons grow after meals, but also the mechanism by which their heart cells are enabled to replicate and how it could be transferred to mammals. According to Tan, once this transferability is fully explored, it is possible that the process could be used to treat the tissue damage associated with heart disease.

Hyperplasia vs. hypertrophy

First, it’s important to understand the difference between the kind of growth that allows for regeneration and the kind of growth that normally occurs in the adult human heart. The first form of growth is called hyperplasia and the second is called hypertrophy.

“Hypertrophy means the cell is growing in size,” explains Tan, a postdoctoral researcher in the Leinwand Lab. “Hyperplasia means the cell is dividing, proliferating, so they are growing in numbers.” Hyperplasia happens because of a cellular process called mitosis, while hypertrophy happens because of an expansion in the volume and surface area of cells.

The human heart undergoes both hyperplasia and hypertrophy, but hyperplasia only happens during fetal development; after that, the heart can only grow when its cells increase in size. Both processes cause growth, but hyperplasia can be regenerative, and hypertrophy can be adaptive. Additionally, although hypertrophy is pathological in the context of cardiac injury, it can also be healthy or physiological, in which case it is reversible. The pythons in this study underwent physiological hypertrophy because no injuries were introduced to their hearts.

Growth after meals

Burmese pythons are predators that consume large prey infrequently, sometimes going months or even more than a year without feeding. When they are between meals, their metabolism is slowed to save energy, but once they begin digesting a large meal, it increases massively.

Correspondingly, the python’s organs, including the heart, grow, expanding by 20 to 40 percent over several days. This growth was generally understood to be driven by hypertrophy because the python’s organs return to their normal size almost as quickly as they grow—it is reversible, just like physiological cardiac hypertrophy in humans. However, the researchers discovered that, if fed enough, the python’s heart would not shrink all the way back to what its weight was before feeding.

“Their organs grow after a big meal,” Tan says, “but it’s very transient, very temporary. After one standard meal, if you look at other papers, the organ shrank back to its original size.” Depending on how much and how often the pythons ate, though, the results were different, as the researchers proved by assigning 24 pythons different feeding regimens and observing how those regimens affected them. The pythons were either “Fasted,” “Normal Fed,” “Frequent Fed” or “Frequent Fed/Fasted.”

Burmese pythons are predators that consume large prey infrequently, sometimes going months or even more than a year without feeding. (Photo: Wikimedia Commons)

“There were frequent feeding regimens, which means we fed them every four days, and they usually average 28 days between meals,” Tan explains. As expected, the Fasted pythons grew the least while the Normal Fed animals grew a bit more and Frequent Fed and Frequent Fed/Fasted pythons grew massively. Meanwhile, although the Frequent Fed and Frequent Fed/Fasted pythons were fed the same amount for eight weeks, the fact that the latter was not fed for four weeks after led to unique results.

While the Frequent Fed/Fasted pythons’ body weight and major organ masses (such as those of the kidney and liver) decreased once they were no longer able to eat so often, the total weight of their hearts remained elevated. This indicates that, while heart growth in Burmese pythons is normally caused by hypertrophy, when they can eat often enough, a different kind of cellular signaling occurs in the heart, and hypertrophic growth is locked in through hyperplasia. So, under the right circumstances, both methods of growth occur, with hypertrophic growth preceding hyperplastic growth.

“It’s a hybrid model,” Tan says. “In the past, we only considered hypertrophy, but in my study, hypertrophy happens first, and then it’s quickly followed up by the hyperplastic process.” Tan says that hyperplasia comes with de-differentiation in this case: The cells that are able to multiply lose their adult functionality during the process.

“During hypertrophy, they don’t want proliferation yet, because cells will de-differentiate and lose contractility. That’s why, at the early stage, when they need the heart to perform, it’s just hypertrophy, but once they complete most of the process, the heart can take a short break, so the cells can divide as well. I propose that’s why hypertrophy happens first.”

Differential gene expression

This leaves an important question: How do Burmese python hearts undergo hyperplasia when adult hearts, including those of these pythons, aren’t normally able to? The answer has to do with the way that genes are expressed by heart cells.

In a previous ��Ҵ�ý�ƽ�� study, researchers showed that the plasma of fed Burmese pythons promoted healthy cardiac hypertrophy in mammals. (Photo: Wikimedia Commons)

Heart cells are capable of hyperplastic growth in principle—they do it during fetal development to form the basic structure of the adult heart. However, after that early stage of development, the heart changes in many ways, including its cells becoming unable to replicate. These two forms of behavior, or differential expressions of the genes, occur because some of the cells’ genes are inactivated after early development.

The genome is like a set of instructions or code that determines how cells behave, with individual genes being like one item in a list of instructions or a line of code. When a gene is inactivated, it is like an item being crossed out or a line of code being commented out: The information isn’t lost, but the way it is annotated tells cells not to follow that part of the instructions or execute that code. Still, something that is crossed out can be rewritten, or something commented out can be uncommented, and this is true for genes as well; a gene that is inactivated can be reactivated.

“You have genes involved in mitotic pathways,” Tan says, “and when they get activated, that will send cells into a mitotic stage, so the cells will prepare themselves for division.” This differential expression is studied through gene set enrichment analysis. “Enrichment simply means these genes in a cluster of genes are activated at the same time,” Tan explains.

Aside from the masses of Frequent Fed pythons’ hearts remaining elevated, the researchers know that mitosis is happening in the animals’ hearts because they observed signals associated with cellular reproduction and because the process was captured with 3D imaging.

“First of all, you see green, because the pHH3 protein is activated, and that means cells are in the mitotic stage,” Tan explains. “For a non-dividing cell, you wouldn’t see anything. Then the figure shows a cell with two nuclei. Everything has one nucleus, but in that cell, there are two, and they’re pulling apart.” This describes the process of mitosis, where the cell duplicates its DNA in its nucleus, the barrier between the nucleus and the rest of the cell breaks down, and the two nuclei—or sets of nucleus content, which will soon become distinct nuclei—are separated into their own cells.

Implications and future research

Although the researchers have good evidence that something in Frequent Fed pythons’ bodies is triggering hyperplastic growth in their hearts, what it is exactly remains unknown. Tan says that the growth was likely triggered by circulating factors in the pythons’ blood plasma. In an earlier study, the researchers showed that the plasma of fed Burmese pythons promoted healthy cardiac hypertrophy in mammals. Along the same lines, the plasma of fed pythons, and especially that of Frequent Fed pythons, activated hyperplasia.

Could pythons' wild feeding habits inspire new treatments for human heart disease?

“The python plasma started the cell cycle again, so that means there’s something there,” Tan says. “You can translate the snake biology to mammals, because the protein activated mammal cells. It’s hard to say if we could use this for drug development, but that’s provisioned here. You identify the factor, synthesize it, and use that. I think it has the potential to be something, but we just don’t know yet.”

A medicine that can regenerate people’s hearts sounds like it would change the world, but because this study did not involve Burmese pythons with injured hearts, we don’t even know how much they could recover using this process yet, much less how well it would work in humans.

“Once people get a heart attack,” Tan says, “the injuries have already happened, and some cells have died already, which will affect your heart function. You can’t just fully recover and get rid of the scar, but at least if the heart cells are able to grow back, even just a little, that’s going to help your overall cardiac function.”

Did you enjoy this article? Subscribe to our newsletter. Passionate about molecular, cellular and developmental biology? Show your support.

��Ҵ�ý�ƽ�� scientists discover the growth of new tissue in Burmese python hearts, which may be transferrable to mammals.

Traditional

White

Craft-beer pioneer is still eyeing the next big thing

Rachel Sauer — Thu, 16 Oct 2025 15:23:37 +0000

Craft-beer pioneer is still eyeing the next big thing Rachel Sauer Thu, 10/16/2025 - 09:23

Clint Talbott

Keith Villa, who invented Blue Moon Belgian White, thinks cannabis-infused beer might take off; he and his wife, Jodi, both ��Ҵ�ý�ƽ�� alums, have launched an alcohol-free brewery that could help lead the way

Keith Villa did not set out to shake up the American beer industry. He’d aimed to become a medical doctor, but his love of biology led him to become a bona fide beer doctor. That led to the kind of career that happens once in a blue moon.

Or, rather, a Blue Moon.

In 1995, Villa invented what’s now known as Molson Coors Blue Moon Belgian White beer. Ultimately, it became the largest craft beer on the market.

Keith Villa (MCDBio'86) got his start in the science of beer by responding a job posting at Coors for someone to do molecular research on how to improve their yeast. (Photo: Jodi Villa)

After more than three decades at Molson Coors, Keith Villa and his wife, Jodi Villa, launched Ceria Brewing Co., which brews alcohol-free beer and is eyeing the potential for alcohol-free beer infused with cannabis. The Villas are still busy innovating, and their latest chapter is still being written.

It’s a tale with several plot twists, but one key player was the University of Colorado Boulder.

Improving yeast

Before college, Keith Villa was inspired by his mother, who was a registered nurse at the Veterans Administration hospital in Denver. He resolved to become a pediatrician.

While in high school, Keith and Jodi met and began to forge their own partnership. They both enrolled at ��Ҵ�ý�ƽ��, he in a pre-med program and she in architectural engineering. Both graduated in 1986.

As a student in molecular, cellular and developmental biology, he worked in the laboratory of Professor Emeritus Lawrence “Larry” Gold, who founded NeXstar Pharmaceuticals.

In the Gold lab, Villa was helping graduate students conduct original research. In 1986, shortly before he graduated with his bachelor’s degree, Villa responded to a job posting at Coors for someone to do molecular research on how to improve their yeast.

“And I thought, ‘Wow, that’s exactly what I’m doing here.’”

Coors hired him more or less immediately, and he went to work trying to design a yeast that would make it cheaper to brew light beer. Although Villa was successful, the yeast was never used commercially, he notes.

After that project concluded, Villa told Coors he was ready to quit to pursue a PhD in biochemistry. Coors’ director of research and development made a counteroffer: Go to Belgium to join a PhD program in brewing, and Coors would foot the bill.

Keith and Jodi didn’t have a mortgage or family yet, so they said, “Let’s do it.”

Studying in Belgium

Belgium was an eye opener. Easy train rides to Germany, Switzerland and beyond widened their horizons to new beers, foods and regional dialects. He conducted his PhD research in Belgium and finished writing his dissertation in Colorado.

Villa’s bosses at Coors said, “Well, you just came back from Belgium. You know about these beers. Can you make something?”

“So that’s when I created Blue Moon,” Villa says.

The top executives at Coors had initial reservations about this new beer: Why was it cloudy and infused with orange peel and coriander, for instance? Eventually, however, Blue Moon became a billion-dollar brand, brewing 2 million barrels a year.

Keith Villa (in the CERIA lab in Brussels, Belgium) earned his PhD at CERIA and named his company in honor of it. (Photo: Jodi Villa)

By 2017, Villa had done “a lot of what I wanted to do in the brewing world,” and he retired from Coors. Soon, he and Jodi launched Ceria Brewing Co., which pays homage to Ceres, the Roman goddess of the harvest. “Ceria” also reflects CERIA, the acronym of the Belgian campus where Keith earned his PhD.

Initially, Ceria produced cannabis-infused beers sold through dispensaries in Colorado and California, and they were aimed at those who consume THC in moderation. But the products faced regulatory hurdles, not least of which is that the federal government doesn’t recognize cannabis as a legitimate business undertaking. The U.S. Drug Enforcement Agency classifies marijuana as a Schedule 1 controlled substance, even though individual states have legalized it to varying degrees.

'Bad movies, hot showers and vanilla'

Today, Ceria offers two non-infused alcohol-free beer styles: Grainwave Belgian-Style White and Indiewave Hoppy IPA. Grainwave is brewed with orange peel and coriander (sound familiar?) and is billed as pairing well with Mexican food, anything spicy, “bad movies, hot showers and vanilla.”

Indiewave, meanwhile, is said to pair well with “charcuterie, Middle Eastern cuisine, after-parties, rainy days, chocolate, your record collection.”

Ceria’s offerings are alcohol free, which differ from “non-alcoholic” beers. According to federal regulations, non-alcoholic beer must be sold with less than 0.5 % alcohol by volume. Alcohol-free beers must have 0.0%.

That distinction matters. One reason is that to infuse beer with THC, the psychotropic ingredient in cannabis, the beer must be alcohol free. And selling cannabis-infused beer could be, in Villa’s estimation, the next big thing.

Hemp-derived THC is a key ingredient. Hemp is distinguished from marijuana largely by the concentration of THC in each; hemp’s concentration is lower. In some states, it’s legal to distribute hemp-derived THC, and selling cannabis-infused beer there is more cost-effective for brewers and consumers.

In states where such sales are legal, Villa notes, consumers can buy cannabis-infused beer in many places, right next to alcoholic beers.

“And when you offer a consumer that choice, you see these beverages just start to take off,” Villa says, adding that there’s a sizable market of people who don’t want to drink alcohol, “or they want to switch back and forth, maybe alcohol this weekend, next weekend cannabis.”

“I would say that we were probably a little ahead of our time with what we did, because now when you look at hemp-derived THC, that really proves our original thesis that beverages with THC are a really great option for people that don’t want alcohol all the time, or they may find alcohol to be bad for their health.”

Now the Villas watch the national market and wait for regulatory changes that could help restart their efforts to sell cannabis-infused beer.

As Villa observed, “We socialize with beverages, and you can’t toast a bride and groom with a gummy.”

Did you enjoy this article? Subscribe to our newsletter. Passionate about molecular, cellular and developmental biology? Show your support.

Traditional

White

Top photo: Jodi and Keith Villa and their daughter, Catherine (right), co-own Ceria Brewing Company. (Photo: Jodi Villa)

��Ҵ�ý�ƽ�� scientist receives $1.25 million award for cancer research

Rachel Sauer — Wed, 18 Jun 2025 17:12:44 +0000

��Ҵ�ý�ƽ�� scientist receives $1.25 million award for cancer research Rachel Sauer Wed, 06/18/2025 - 11:12

Edward Chuong is one of five researchers nationwide awarded funding to pursue ‘daring, paradigm-shifting research’ on cancer immunotherapy treatment

Edward Chuong, a University of Colorado Boulder assistant professor of molecular, cellular and developmental biology and a BioFrontiers Institute scientist, has been awarded $1.25 million by the New York City-based Cancer Research Institute (CRI) to pursue his cancer immunotherapy research.

Chuong was one of five researchers nationwide who received the unrestricted funding over a five-year period, which CRI said is designed to allow researchers to pursue high-risk, high-reward projects that could redefine cancer treatment. The organization called the researchers “scientific leaders poised to reshape cancer immunotherapy through daring, paradigm-shifting research.”

Edward Chuong, a ��Ҵ�ý�ƽ�� assistant professor of molecular, cellular and developmental biology and a BioFrontiers Institute scientist, recently was awarded $1.25 million by the Cancer Research Institute to pursue cancer immunotherapy research.

“These are people who are hitting their stride scientifically and career-wise, and this is where you really want to put some jet fuel in the tank as they are getting established,” said Dr. E. John Wherry, associate director of CRI’s Scientific Advisory Council.

Echoing Wherry’s sentiment, Dr. Alicia Zhou, CRI chief executive officer, added, “Each of these researchers brings fearless curiosity and a willingness to challenge assumptions – the very qualities that drive breakthroughs. They aren’t just advancing cancer science; they are reinventing it.”

Chuong said he was surprised and honored to receive CRI funding for his research.

“As someone from an evolutionary biology background, this award means my outsider ideas are being welcomed into the cancer research community. It’s a huge boost,” he said.

Chuong’s research focuses on the role that ancient viral fragments in human DNA, called transposons, play in regulating immune cell signaling.

“Our lab started out exploring the evolution of transposons—bits of DNA derived from genetic parasites—and discovered they may function as hidden switches in our immune system,” Chuong said. “With this support, we’ll investigate how cancer cells hijack these switches to escape detection, and use that knowledge to develop new markers and therapies that make immunotherapy work better for more patients. I’m grateful to the Cancer Research Institute for supporting this unconventional perspective and I’m incredibly excited to see where it leads.”

Each year, CRI awards funding for scientists to pursue their research through its grant-making program honoring its founding scientific and medical director, Lloyd J. Old. The organization said its Lloyd J. Old STAR program—Scientists TAking Risks—is designed to provide long-term funding to mid-career scientists, giving them the freedom and flexibility to pursue research “at the forefront of discovery and innovation in cancer immunotherapy.”

CRI said its awards are given out based upon its “exceptional track record of identifying and supporting people who have had a major impact in immunotherapy.” The organization said its grants are not tied to a specific research project but rather support outstanding researchers based upon the quality and promise of researchers’ overall work.

Did you enjoy this article? Subscribe to our newsletter. Passionate about molecular, cellular and developmental biology? Show your support.

Edward Chuong is one of five researchers nationwide awarded funding to pursue ‘daring, paradigm-shifting research’ on cancer immunotherapy treatment.

Traditional

White

��Ҵ�ý�ƽ�� prof named Boettcher Investigator

Rachel Sauer — Fri, 06 Jun 2025 18:38:17 +0000

��Ҵ�ý�ƽ�� prof named Boettcher Investigator Rachel Sauer Fri, 06/06/2025 - 12:38

Assistant Professor Jennifer Hill is one of seven Colorado researchers to be recognized by the Boettcher Foundation for their pioneering biomedical research

The Boettcher Foundation and Colorado BioScience Association (CBSA) have named Assistant Professor Jennifer H. Hill with the University of Colorado Boulder’s Department of Molecular, Cellular and Developmental Biology and BioFrontiers Institute as one of seven outstanding early-career biomedical researchers.

Each scientist will receive a $250,000 grant through the Boettcher Foundation’s Webb-Waring Biomedical Research Awards Program to support up to three years of independent scientific research, with total grant funding reaching $1.75 million.

��Ҵ�ý�ƽ�� scientist Jennifer Hill, an assistant professor of molecular, cellular and developmental biology, has been named a 2025 Boettcher Investigator.

“It’s a huge honor to be selected as one of this year’s Boettcher Investigators, especially given the depth of groundbreaking biomedical research in Colorado,” Hill said. “The award gives my lab the resources to explore the relevance of our work in human tissues, bringing us closer to our goal of preventing type 1 diabetes in children. As a young investigator, receiving funds like these goes a long way to help offset some of the anxiety and uncertainty in the current federal funding landscape.”

This year’s class represents the next generation of scientific excellence and marks another milestone in Boettcher Foundation’s 16-year commitment to strengthening Colorado’s biomedical research ecosystem, according to the Boettcher Foundation. The Webb-Waring Biomedical Research Awards provide crucial early-career support and position recipients to compete for additional private, state and federal research funding.

“We are delighted to support our 2025 Boettcher Investigators, and as champions of their work, we are confident that these researchers will continue to spark new discoveries and drive innovation in medicine,” said Katie Kramer, president and CEO of the Boettcher Foundation. “The far-reaching impact of our Investigators’ research extends well beyond the lab—each advancement sets in motion a ripple effect that benefits patients, strengthens Colorado’s scientific community, and inspires future breakthroughs. We are proud to invest in these remarkable scientists, whose dedication and creativity are shaping a healthier future for all.”

Hill is a microbe scientist who studies the connection between the pancreas and microbes in the gut, examining microbiota in the development of insulin-producing beta cells. Four Boettcher Investigators with the University of Colorado Anschutz Medical Campus and two with Colorado State University are pursuing research into fields including osteoarthritis, autism spectrum disorder, cancer and autoimmune diseases, and developmental and neurological disorders.

Since its inception, the Webb-Waring Biomedical Research Awards Program has supported 113 Boettcher Investigators, including this year’s class, and awarded close to $27 million in grant funding. These researchers have gone on to secure more than $150 million in additional research funding from federal, state and private sources, according to the Boettcher Foundation.

“Colorado BioScience Association is grateful to the Boettcher Foundation for its continued investment in the next generation of scientific leaders in our state,” said Elyse Blazevich, president and CEO of Colorado BioScience Association. “The Webb-Waring Biomedical Research Awards provide essential early-career funding that empowers researchers to remain in Colorado and advance their discoveries within our world-class academic and research institutions. We are honored to celebrate the accomplishments of the 2025 class of Boettcher Investigators.”

Did you enjoy this article? Subscribe to our newsletter. Passionate about molecular, cellular and developmental biology? Show your support.

Assistant Professor Jennifer Hill is one of seven Colorado researchers to be recognized by the Boettcher Foundation for their pioneering biomedical research.

Traditional

White

Molecular, Cellular and Developmental Biology

��Ҵ�ý�ƽ�� scholars elected members of the National Academy of Sciences

Related Articles

Sometimes you just feel like a mango

Related Articles

��Ҵ�ý�ƽ�� scientists honored as AAAS fellows

Related Articles

Scientist lives by the Serengeti Rules

Related Articles

Three ��Ҵ�ý�ƽ�� faculty named 2026 Sloan Research Fellows

Related Articles

Grad’s work fuses the arts and sciences

Related Articles

Research on python hearts has possible implications for human medicine

Related Articles

Craft-beer pioneer is still eyeing the next big thing

Related Articles

��Ҵ�ý�ƽ�� scientist receives $1.25 million award for cancer research

Related Articles

��Ҵ�ý�ƽ�� prof named Boettcher Investigator

Related Articles

Molecular, Cellular and Developmental Biology

���Ҵ�ý�ƽ������ scholars elected members of the National Academy of Sciences

Related Articles

Sometimes you just feel like a mango

Related Articles

���Ҵ�ý�ƽ������ scientists honored as AAAS fellows

Related Articles

Scientist lives by the Serengeti Rules

Related Articles

Three ���Ҵ�ý�ƽ������ faculty named 2026 Sloan Research Fellows

Related Articles

Grad’s work fuses the arts and sciences

Related Articles

Research on python hearts has possible implications for human medicine

Related Articles

Craft-beer pioneer is still eyeing the next big thing

Related Articles

���Ҵ�ý�ƽ������ scientist receives $1.25 million award for cancer research

Related Articles

���Ҵ�ý�ƽ������ prof named Boettcher Investigator

Related Articles

��Ҵ�ý�ƽ�� scholars elected members of the National Academy of Sciences

��Ҵ�ý�ƽ�� scientists honored as AAAS fellows

Three ��Ҵ�ý�ƽ�� faculty named 2026 Sloan Research Fellows

��Ҵ�ý�ƽ�� scientist receives $1.25 million award for cancer research

��Ҵ�ý�ƽ�� prof named Boettcher Investigator